Teachers Retirement System Of The State Of Kentucky Madrigal Pharmaceuticals, Inc. Transaction History

Teachers Retirement System Of The State Of Kentucky

$11.4 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 07, 2022	SELL	$55.89 - $101.89 $615,684 - $1.12 Million	-11,016 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$78.35 - $105.02 $120,267 - $161,205	1,535 Added 16.19%	11,016 $879,000
Q2 2021 Jul 28, 2021	BUY	$97.2 - $137.59 $104,198 - $147,496	1,072 Added 12.75%	9,481 $924,000
Q1 2021 May 19, 2021	SELL	$108.54 - $125.2 $52,207 - $60,221	-481 Reduced 5.41%	8,409 $984,000
Q4 2020 Mar 08, 2021	BUY	$110.06 - $133.7 $289,457 - $351,630	2,630 Added 42.01%	8,890 $988,000
Q4 2019 Feb 13, 2020	BUY	$84.28 - $118.5 $144,203 - $202,753	1,711 Added 37.61%	6,260 $570,000
Q3 2019 Nov 07, 2019	BUY	$84.4 - $106.53 $183,907 - $232,128	2,179 Added 91.94%	4,549 $392,000
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $65,580 - $149,153	692 Added 41.24%	2,370 $267,000
Q3 2018 Nov 08, 2018	BUY	$207.3 - $300.31 $347,849 - $503,920	1,678 New	1,678 $359,000

Others Institutions Holding MDGL

# of Institutions

338

Shares Held

22.7M

Call Options Held

757K

Put Options Held

960K

Janus Henderson Group PLC London, X0

2.21M
Shares

$745 Million
0.36% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$689 Million
38.14% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$684 Million
9.12% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$672 Million
10.03% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$666 Million
6.75% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.77B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.

Account